DOJ

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Cummins Inc. - CMI

Retrieved on: 
Sunday, February 11, 2024

NEW YORK, Feb. 11, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Cummins Inc. (“Cummins” or the “Company”) (NYSE: CMI).

Key Points: 
  • NEW YORK, Feb. 11, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Cummins Inc. (“Cummins” or the “Company”) (NYSE: CMI).
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • The class action concerns whether Cummins Solutions and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against iRhythm Technologies, Inc. - IRTC

Retrieved on: 
Sunday, February 11, 2024

NEW YORK, Feb. 11, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against iRhythm Technologies, Inc. (“iRhythm” or the “Company”) (NASDAQ: IRTC).

Key Points: 
  • NEW YORK, Feb. 11, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against iRhythm Technologies, Inc. (“iRhythm” or the “Company”) (NASDAQ: IRTC).
  • The class action concerns whether iRhythm and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • You have until April 8, 2024, to ask the Court to appoint you as Lead Plaintiff for the class if you are a shareholder who purchased or otherwise acquired iRhythm securities during the Class Period.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Calavo Growers, Inc.

Retrieved on: 
Sunday, February 11, 2024

NEW YORK, Feb. 11, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Calavo Growers, Inc. (“Calavo” or the “Company”) (NASDAQ: CVGW).

Key Points: 
  • NEW YORK, Feb. 11, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Calavo Growers, Inc. (“Calavo” or the “Company”) (NASDAQ: CVGW).
  • The investigation concerns whether Calavo and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
  • The Firm has recovered billions of dollars in damages awards on behalf of class members.

Anti-Corruption Enforcement 2023 Year in Review

Retrieved on: 
Friday, February 9, 2024

CHICAGO and LONDON, Feb. 9, 2024 /PRNewswire/ -- Jenner & Block published its annual Anti-Corruption Enforcement Year in Review , a comprehensive analysis of significant developments in anti-corruption laws and practices worldwide.

Key Points: 
  • CHICAGO and LONDON, Feb. 9, 2024 /PRNewswire/ -- Jenner & Block published its annual Anti-Corruption Enforcement Year in Review , a comprehensive analysis of significant developments in anti-corruption laws and practices worldwide.
  • "Our commitment is not merely to interpret the law but to advocate for the pursuit of justice and safeguard legal foundations.
  • We aim for this Anti-Corruption Enforcement Year in Review to serve as an easy-to-follow and engaging resource."
  • "There's never a dull moment in the UK's fight against corruption, and 2023 was no exception.

IRHYTHM DEADLINE ALERT: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In iRhythm To Contact Him Directly To Discuss Their Options

Retrieved on: 
Thursday, February 8, 2024

NEW YORK, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against iRhythm Technologies, Inc. (“iRhythm” or the “Company”) (NASDAQ: IRTC) and reminds investors of the April 8, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Key Points: 
  • If you suffered losses exceeding $100,000 investing in iRhythm stock or options between January 11, 2022, and May 30, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext.
  • Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Pennsylvania, California and Georgia.
  • As a result of these misrepresentations, the price of iRhythm common stock traded at artificially inflated prices throughout the Class Period.
  • Faruqi & Faruqi, LLP also encourages anyone with information regarding iRhythm’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

IRHYTHM ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against iRhythm Technologies, Inc. and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, February 8, 2024

Investors have until April 8, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until April 8, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • iRhythm develops and manufactures heart monitoring devices designed to diagnose arrythmias.
  • The Company’s principal product is a monitoring patch that provides electrocardiogram (“ECG”) monitoring for up to 14 days, called Zio XT.
  • As a result of these misrepresentations, the price of iRhythm common stock traded at artificially inflated prices throughout the Class Period.

Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of iRhythm Technologies, Inc. (IRTC) Investors

Retrieved on: 
Wednesday, February 7, 2024

Investors have until April 8, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until April 8, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • The lawsuit alleges that, throughout the Class Period, iRhythm failed to disclose serious issues with its Zio AT heart monitor to the FDA, patients, or investors.
  • As a result of these representations, the price of iRhythm common stock traded at artificially inflated prices throughout the Class Period.
  • Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation.

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Calavo Growers, Inc. (CVGW) on Behalf of Investors

Retrieved on: 
Wednesday, February 7, 2024

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Calavo Growers, Inc. (“Calavo” or the “Company”) (NASDAQ: CVGW ) investors concerning the Company’s possible violations of the federal securities laws.

Key Points: 
  • Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Calavo Growers, Inc. (“Calavo” or the “Company”) (NASDAQ: CVGW ) investors concerning the Company’s possible violations of the federal securities laws.
  • You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.
  • Then, on January 31, 2024, after the market closed, Calavo released its fourth quarter and full year 2023 financial results, which missed consensus revenue estimates.
  • Whistleblower Notice: Persons with non-public information regarding Calavo should consider their options to aid the investigation or take advantage of the SEC Whistleblower Program.

DOJ funding pipeline subsidizes questionable big data surveillance technologies

Retrieved on: 
Wednesday, February 7, 2024

Yet, the Department of Justice has been funding the crime surveillance and analysis technology for years and continues to do so despite criticism from researchers, privacy advocates and members of Congress.

Key Points: 
  • Yet, the Department of Justice has been funding the crime surveillance and analysis technology for years and continues to do so despite criticism from researchers, privacy advocates and members of Congress.
  • Sen. Ron Wyden, D-Ore., and U.S. Rep. Yvette Clarke, D-N.Y., joined by five Democratic senators, called on Attorney General Merrick Garland to halt funding for predictive policing technologies in a letter issued Jan. 29, 2024.
  • Predictive policing involves analyzing crime data in an attempt to identify where and when crimes are likely to occur and who is likely to commit them.
  • While focused on predictive policing, the senators’ demand raises what I, a law professor who studies big data surveillance, see as a bigger issue: What is the Department of Justice’s role in funding new surveillance technologies?

The money pipeline

  • Because there was grant money available to test out new theories, academics and startup companies could afford to invest in new ideas.
  • Police departments also benefit from getting money to buy the new technology without having to dip into their local budgets.
  • As these DOJ entities’ practices indicate, federal money not only seeds but feeds the growth of new policing technologies.
  • Since 2005, the Bureau of Justice Assistance has given over $7.6 billion of federal money to state, local and tribal law enforcement agencies for a host of projects.

The questions not asked

  • The Department of Justice is in the business of prosecution, so it is not surprising for it to fund prosecution tools.
  • As someone who has studied predictive policing for over a decade, I can say that the questions asked by the senators were not asked in the pilot projects.
  • Basic questions of who would be affected, whether there could be a racially discriminatory impact, how it would change policing and whether it worked were not raised in any serious way.
  • Only now, after activists have protested, after scholars have critiqued and after the original predictive policing companies have shut down or been bought by bigger companies, is the DOJ starting to ask the hard questions.

Lessons not learned?

  • As one example, real-time crime centers are being built across America.
  • Thousands of security cameras stream to a single command center that is linked to automated license plate readers, gunshot detection sensors and 911 calls.
  • Real-time crime centers can do predictive analytics akin to predictive policing simply as a byproduct of all the data they collect in the ordinary course of a day.
  • The centers can also scan entire cities with powerful computer vision-enabled cameras and react in real time.
  • The capabilities of these advanced technologies make the civil liberties and racial justice fears around predictive policing pale in comparison.


I have worked as an unpaid consultant on two NIJ grants. I did not receive any compensation. One grant was an early NIJ grant to the Risk Terrain Modeling folks at Rutgers (which became Simsi). I have not had any relationship with them in years and took no money. I was also on an NIJ grant around the ethics of predictive policing. Again, I did not receive any financial compensation for the role.

Shareholder Alert: Bernstein Litowitz Berger & Grossmann LLP Announces the Filing of Securities Class Action Lawsuit Against iRhythm Technologies, Inc.

Retrieved on: 
Wednesday, February 7, 2024

The action is brought on behalf of all persons or entities that purchased or otherwise acquired iRhythm common stock between January 11, 2022, and May 30, 2023, inclusive (the “Class Period”).

Key Points: 
  • The action is brought on behalf of all persons or entities that purchased or otherwise acquired iRhythm common stock between January 11, 2022, and May 30, 2023, inclusive (the “Class Period”).
  • The complaint is based on an extensive investigation and a careful evaluation of the merits of this case.
  • The Company’s principal product is a monitoring patch that provides electrocardiogram (“ECG”) monitoring for up to 14 days, called Zio XT.
  • As a result of these misrepresentations, the price of iRhythm common stock traded at artificially inflated prices throughout the Class Period.